ArticleJournal for immunotherapy of cancer2025

Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8

Shuaishuai Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.